A possible mechanism of choleretic action of 3-(2,4,5-triethoxybenzoyl)-propionic acid (AA-149) in dogs.
The choleretic action of 3-(2,4,5-triethoxybenzoyl)propionic acid (AA-149) was studied in anesthetized dogs. AA-149 produced a dose-dependent increase of the bile flow with both i.v. and intrajejunal administration of doses 1 mg/kg and higher. Biliary clearance of 14C-erythritol showed that AA-149 stimulated canalicular bile formation without enhancement of water secretion and/or inhibition of bile reabsorption in the biliary ductules and ducts. AA-149 did not increase the excretion of bile acids into the bile, but enhanced the excretion of the biliary electrolytes, in particular sodium ion, in proportion to an increase of the bile flow. About 3--4% of AA-149 administered i.v. was excreted into the bile during the first 1 h period, so that biliary AA-149 was insufficient to increase the bile flow via its osmotic effect. These results strongly suggest that the choleretic action of AA-149 is attributable to stimulation of a bile acid-independent bile formation in the canaliculi coupled with an active sodium transport system.
D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D001646:Bile / Q000378:metabolism; D001647:Bile Acids and Salts / Q000378:metabolism; D002415:Cats; D002756:Cholagogues and Choleretics / Q000494:pharmacology*; D004285:Dogs; D004896:Erythritol / Q000378:metabolism; D005260:Female; D006168:Guinea Pigs; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009994:Osmolar Concentration; D011422:Propionates / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013656:Taurocholic Acid / Q000494:pharmacology; D013997:Time Factors
D001565:Benzoates; D001647:Bile Acids and Salts; D002756:Cholagogues and Choleretics; D011422:Propionates; D013656:Taurocholic Acid; D004896:Erythritol